NDC 0517-0791 – Betamethasone Sodium Phosphate and Betamethasone Acetate
Betamethasone Acetate 3 mg/mL; Betamethasone Sodium Phosphate 3 mg/mL · Injection, Suspension · Intra-articular, Intralesional, Intramuscular
Product NDC0517-0791
Product details
- Brand name
- Betamethasone Sodium Phosphate and Betamethasone Acetate
- Generic name
- Betamethasone Sodium Phosphate and Betamethasone Acetate
- Labeler
- American Regent, Inc.
- Dosage form
- Injection, Suspension
- Route
- Intra-articular, Intralesional, Intramuscular
- Marketing category
- ANDA · ANDA090747
- Marketed since
- November 1, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Corticosteroid; Corticosteroid
Active ingredients
- Betamethasone Acetate 3 mg/mL
- Betamethasone Sodium Phosphate 3 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0517-0791-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (0517-0791-01) / 5 mL in 1 VIAL, MULTI-DOSE | Nov 1, 2019 |
Other Betamethasone Sodium Phosphate and Betamethasone Acetate products
- 0517-0720 Betamethasone Acetate 3 mg/mL; Betamethasone Sodium Phosphate 3 mg/mL · Injection, Suspension · American Regent, Inc.
- 0517-0799 Betamethasone Acetate 3 mg/mL; Betamethasone Sodium Phosphate 3 mg/mL · Injection, Suspension · American Regent, Inc.
- 76420-007 Betamethasone Acetate 3 mg/mL; Betamethasone Sodium Phosphate 3 mg/mL · Injection, Suspension · Asclemed USA, Inc.